glp 1 mounjaro vs ozempic Could GLP-1 Weight Loss Drugs Also Treat or Prevent Chronic Diseases? Mounjaro® vs Ozempic® for Weight

From short-acting to long-acting formulations, the wide range of GLP- 1 receptor agonists available provides physicians with numerous options to tailor treatment to each patient's needs

Novos own data show its obesity-care sales up 56% and global obesity drug demand up 119%

If you take a sub-therapeutic dose, meaning a dose thats too low to work correctly, then the medicine probably wont help you

A New Star is Born: Wegovy Ozempic isn't the only star in the GLP-1 weight management universe

IDEA Pharma's latest global report explores where innovation is happening, how companies are performing, and what trends are reshaping the competitive landscape

Research in well-known medical journals shows no big jump in cancer cases compared to those taking placebos